Influence of Intensive versus Conventional Glucose Control on Microvascular and Macrovascular Complications in Type 1 and 2 Diabetes Mellitus

被引：0
|
作者：
Taina K. Mattila
Anthonius de Boer
机构：
[1] Utrecht University,Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS)
来源：
Drugs | 2010年 / 70卷
关键词：
Metformin; Rosiglitazone; Pioglitazone; Microvascular Complication; Severe Hypoglycaemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In type 1 and 2 diabetes mellitus patients, hyperglycaemia is independently related to the development of microvascular and macrovascular complications. Glycaemic targets and the benefits of intensive versus conventional glucose control are under debate. The purpose of this review is to provide an overview of the randomized controlled trials and meta-analyses comparing the effects of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes.
引用
收藏
页码：2229 / 2245
页数：16
相关论文
共 50 条
  • [31] ANALYSIS OF GLYCEMIC CONTROL AND MICROVASCULAR COMPLICATIONS IN TYPE 2 DIABETES AND CONTROL OF GLUCOSE
    Shaikh, Ayesha Tahsin
    Sajjad, Rabia
    Shahid, Ayesha
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (08): : 7998 - 8001
  • [32] Pharmacologic Prevention of Microvascular and Macrovascular Complications in Diabetes Mellitus Implications of the Results of Recent Clinical Trials in Type 2 Diabetes
    Tandon, Nikhil
    Ali, Mohammed K.
    Narayan, K. M. Venkat
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (01) : 7 - 22
  • [33] Glycaemic control and macrovascular complications of type 2 diabetes
    Dandona, Paresh
    Chaudhuri, Ajay
    NATIONAL MEDICAL JOURNAL OF INDIA, 2008, 21 (06): : 271 - 274
  • [34] Does blood glucose control prevent macrovascular complications of type 2 diabetes? DISCUSSION
    Villet, Richard
    Bouchard, Philippe
    Godeau, Pierre
    Bringer, Jacques
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2018, 202 (5-6): : 906 - 908
  • [35] Microvascular Complications in Adolescents with Type 1 Diabetes Mellitus
    Demirel, Fatma
    Tepe, Derya
    Kara, Ozlem
    Esen, Ihsan
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2013, 5 (03) : 145 - 149
  • [36] Clustering of microvascular complications in Type 1 diabetes mellitus
    Bjerg, Lasse
    Hulman, Adam
    Charles, Morten
    Jorgensen, Marit Eika
    Witte, Daniel Rinse
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2018, 32 (04) : 393 - 399
  • [37] Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?
    Bejan-Angoulvant, T.
    Cornu, C.
    Archambault, P.
    Tudrej, B.
    Audier, P.
    Brabant, Y.
    Gueyffier, F.
    Boussageon, R.
    DIABETES & METABOLISM, 2015, 41 (03) : 195 - 201
  • [38] Children with type 2 diabetes mellitus are at greater risk of macrovascular complications
    Shiga, Kentaro
    Kikuchi, Nobuyuki
    PEDIATRICS INTERNATIONAL, 2009, 51 (04) : 563 - 567
  • [39] Frequency and progression of macrovascular complications in a population with type 2 diabetes mellitus
    Pedula, KL
    Brown, JB
    Lydick, E
    DIABETES, 1999, 48 : A364 - A364
  • [40] Kinin - kallikrein system with macrovascular complications of diabetes mellitus type 2
    Vorob'ev, S.
    Mikashinovich, Z., I
    Chernogubova, E. A.
    DIABETES MELLITUS, 2005, 8 (04): : 6 - 9
12345